AC

Alfred Childers

Description

Alfred Childers founder Magellan Laboratories.

Investor Profile

Alfred Childers has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Nanotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alfred Childers frequently co-invest with?

Next47
North America, California, United States, Palo Alto
Co-Investments: 1
Wakefield Group
North America, North Carolina, United States, Charlotte
Co-Investments: 1
Firelake Capital Management
North America, California, United States, Palo Alto
Co-Investments: 1
Siemens
Europe, Bayern, Germany, Munich
Co-Investments: 1

Which angels does Alfred Childers often collaborate with?

WS
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
W. Lowry Caudill
North America, North Carolina, United States, Durham
Shared Deals: 1

What are some of recent deals done by Alfred Childers?

Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Series AJun 14, 2006
Amount Raised: $6,000,000